MA26442A1 - Derives de 1-carba-(dethia)-cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation - Google Patents

Derives de 1-carba-(dethia)-cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation

Info

Publication number
MA26442A1
MA26442A1 MA24807A MA24807A MA26442A1 MA 26442 A1 MA26442 A1 MA 26442A1 MA 24807 A MA24807 A MA 24807A MA 24807 A MA24807 A MA 24807A MA 26442 A1 MA26442 A1 MA 26442A1
Authority
MA
Morocco
Prior art keywords
dethia
carba
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
MA24807A
Other languages
English (en)
Inventor
Angehrn Peter
Heinze-Krauss Ingrid
Page Malcolm
Hebeisen Paul
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26442A1 publication Critical patent/MA26442A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA24807A 1996-09-23 1997-09-23 Derives de 1-carba-(dethia)-cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation MA26442A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96115210 1996-09-23

Publications (1)

Publication Number Publication Date
MA26442A1 true MA26442A1 (fr) 2004-12-20

Family

ID=8223209

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24807A MA26442A1 (fr) 1996-09-23 1997-09-23 Derives de 1-carba-(dethia)-cephalosporine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation

Country Status (23)

Country Link
US (1) US5939410A (fr)
JP (1) JPH10101670A (fr)
KR (1) KR100256473B1 (fr)
CN (1) CN1184110A (fr)
AR (1) AR008450A1 (fr)
AU (1) AU723176B2 (fr)
BR (1) BR9704770A (fr)
CA (1) CA2216222A1 (fr)
CO (1) CO4900072A1 (fr)
CZ (1) CZ292097A3 (fr)
HR (1) HRP970511A2 (fr)
HU (1) HUP9701548A3 (fr)
ID (1) ID18323A (fr)
IL (1) IL121798A0 (fr)
MA (1) MA26442A1 (fr)
NO (1) NO974366L (fr)
NZ (1) NZ328595A (fr)
PE (1) PE110098A1 (fr)
PL (1) PL322240A1 (fr)
SG (1) SG53049A1 (fr)
TR (1) TR199701011A2 (fr)
YU (1) YU38497A (fr)
ZA (1) ZA978332B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101835777A (zh) * 2007-10-25 2010-09-15 尔察祯有限公司 碳头孢烯β-内酰胺抗生素
WO2010030810A1 (fr) * 2008-09-10 2010-03-18 Achaogen, Inc. Antibiotiques de type béta-lactame à base de carbacéphème

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112481A1 (fr) * 1982-11-12 1984-07-04 Kyowa Hakko Kogyo Co., Ltd Dérivé de bêta-lactame
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
EP0620225B1 (fr) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Dérivés de céphalosporine
BR9607046A (pt) * 1995-02-27 1997-12-30 Hoffmann La Roche Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
EP0761673A1 (fr) * 1995-09-12 1997-03-12 F. Hoffmann-La Roche Ag Dérivés de céphalosporine

Also Published As

Publication number Publication date
CO4900072A1 (es) 2000-03-27
ZA978332B (en) 1998-03-23
YU38497A (sh) 1999-12-27
TR199701011A2 (xx) 1998-04-21
CN1184110A (zh) 1998-06-10
KR100256473B1 (ko) 2000-05-15
AU3838297A (en) 1998-01-15
SG53049A1 (en) 1998-09-28
PL322240A1 (en) 1998-03-30
HUP9701548A3 (en) 2001-04-28
HUP9701548A2 (hu) 1999-05-28
IL121798A0 (en) 1998-02-22
KR19980024863A (ko) 1998-07-06
NO974366D0 (no) 1997-09-22
CZ292097A3 (cs) 1998-04-15
HU9701548D0 (en) 1997-11-28
US5939410A (en) 1999-08-17
NO974366L (no) 1998-03-24
HRP970511A2 (en) 1998-08-31
AR008450A1 (es) 2000-01-19
BR9704770A (pt) 1998-11-03
NZ328595A (en) 1999-01-28
JPH10101670A (ja) 1998-04-21
AU723176B2 (en) 2000-08-17
MX9707201A (es) 1998-06-28
CA2216222A1 (fr) 1998-03-23
PE110098A1 (es) 1999-01-13
ID18323A (id) 1998-03-26

Similar Documents

Publication Publication Date Title
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26468A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26432A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26479A1 (fr) Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26425A1 (fr) Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26526A1 (fr) Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26443A1 (fr) Aralkyl- et aralkylidene-lactames et -imides heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
MA26465A1 (fr) Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26470A1 (fr) Derives de 1,3,8-triazaspiro (4,5) decane-4-one substitues en position 8, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26414A1 (fr) Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
FR2735777B1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26505A1 (fr) Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26422A1 (fr) Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.